BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35679701)

  • 1. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
    Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
    Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Prognostic Factors and Genotypes in Patients With Breast Cancer Using Multiple Mathematical Models of MR Diffusion Imaging.
    Wang W; Zhang X; Zhu L; Chen Y; Dou W; Zhao F; Zhou Z; Sun Z
    Front Oncol; 2022; 12():825264. PubMed ID: 35174093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
    Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
    J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XGboost Prediction Model Based on 3.0T Diffusion Kurtosis Imaging Improves the Diagnostic Accuracy of MRI BiRADS 4 Masses.
    Tang W; Zhou H; Quan T; Chen X; Zhang H; Lin Y; Wu R
    Front Oncol; 2022; 12():833680. PubMed ID: 35372060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoexponential diffusion-weighted imaging and diffusion kurtosis imaging and dynamic contrast-enhanced-MRI for the differentiation of spinal tumors.
    Zhang J; Chen Y; Zhang E; Li N; Yuan H; Lang N
    Eur Spine J; 2020 May; 29(5):1112-1120. PubMed ID: 32040617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
    Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
    J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the Nottingham prognostic index and molecular subtypes of breast cancer through multimodal magnetic resonance imaging.
    Chen K; Yu C; Pan J; Xu Y; Luo Y; Yang T; Yang X; Xie L; Zhang J; Zhuo R
    Magn Reson Imaging; 2024 May; 108():168-175. PubMed ID: 38408689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Differentiating Benign and Malignant Head and Neck Lesions.
    Cheng J; Shao S; Chen W; Zheng N
    J Magn Reson Imaging; 2022 Feb; 55(2):414-423. PubMed ID: 34378259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
    Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
    J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Effects of Anti-PD-1 Therapy on Triple-Negative Breast Cancer in Mice by Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Imaging.
    Tang WJ; Yao W; Jin Z; Kong QC; Hu WK; Liang YS; Chen LX; Chen SY; Zhang QQ; Wei XH; Xu XD; Guo Y; Jiang XQ
    J Magn Reson Imaging; 2022 Dec; 56(6):1912-1923. PubMed ID: 35499275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors.
    Huang N; Chen Y; She D; Xing Z; Chen T; Cao D
    Eur Radiol; 2022 Apr; 32(4):2748-2759. PubMed ID: 34642805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.
    Xie T; Jiang T; Zhao Q; Fu C; Nickel MD; Peng W; Gu Y
    J Magn Reson Imaging; 2023 Jul; 58(1):81-92. PubMed ID: 36433714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
    Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
    Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.